Targeted therapy
In this treatment, drugs are used that focus only on the special functions of the cancerous cells. This treatment works in many ways, such as directly killing the leukemia cells, it may cut off the supply of blood to the leukemia cells that are crucial for their development, or these drugs hinder their capacity to reproduce or grow. There are many types of targeted therapies used; some of these are venetoclax, ibrutinib, ivisitinib, midostaurin, gilteritinib, fedratinib, ruxolitinib, ponatinib, nilotinib, dasatinib all of these work as tyrosine inhibitors. Some antibodies are also included, such as alemtuzumab, obinatuzumab, ofatumumab, rituximab, gemtuzumab, and inotuzumab.